Aniesis is a biotechnology company focused on expanding healthcare access in underserved regions. With over 80 years of combined life science experience, our team has advanced preclinical candidates to first in human trials, delivering impact for partners and patients alike. We address healthcare gaps across Africa, South Asia, Southeast Asia, Latin America, Central Asia, parts of the Middle East, and Pacific Island nations, bringing next generation therapies to communities where infrastructure and R&D capacity are limited. Through precision biology, AI driven screening, and real world data, we tailor drug discovery to local needs. Our alliances with academic, nonprofit, and industry leaders power an end to end innovation ecosystem, from target identification to in vivo validation. Aniesis’s modular R&D campus provides integrated services including screening, lead optimization, pharmacokinetics, and safety, designed to move medicines faster to where they're needed most.